FIELD: medicine.
SUBSTANCE: present invention relates to immunology. Disclosed is a composition for the treatment of IL-13 mediated disorder, comprising an anti-IL13 antibody and a residual amount of a hamster PLBL2. Purified preparations of the anti-IL13 antibody, a method for purifying a recombinant polypeptide from a hamster PLBL2, are also disclosed. In addition, a method for treating IL-13 mediated disorder in a patient is described.
EFFECT: present invention may find further application in the therapy of various conditions, in particular asthma, idiopathic pulmonary fibrosis and atopic dermatitis.
63 cl, 7 dwg, 16 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND COMPOSITIONS INCLUDING PURIFIED RECOMBINANT POLYPEPTIDES | 2014 |
|
RU2793783C1 |
| PURIFICATION OF ANTIBODIES WITH CATION-EXCHANGE CHROMATOGRAPHY | 2008 |
|
RU2498991C2 |
| ANTIBODIES WITH REDUCED BINDING WITH TECHNOLOGICAL IMPURITIES | 2017 |
|
RU2771330C2 |
| NOVEL ANTI-IL13 ANTIBODIES AND USE THEREOF | 2004 |
|
RU2487887C2 |
| USING ANTI-CD40-ANTIBODIES | 2008 |
|
RU2491095C2 |
| METHODS OF THE PROTEINS DOWNSTREAM PURIFICATION EFFICIENCY INCREASING WITH THE USE OF MEMBRANE ION EXCHANGE CHROMATOGRAPHY | 2012 |
|
RU2648999C2 |
| ANTI-MESOTHELIN ANTIBODY AND CONJUGATE THEREOF WITH MEDICINAL PRODUCTS | 2019 |
|
RU2747995C1 |
| METHODS OF PURIFYING SINGLE-DOMAIN ANTIGEN-BINDING MOLECULES | 2009 |
|
RU2553214C2 |
| COMPOSITIONS RELATED TO CLOSTRIDIUM DIFFICILE MUTANT TOXIN, AND METHODS OF APPLICATION THEREOF | 2012 |
|
RU2592686C2 |
| ANTI-PTK7 ANTIBODY-DRUG CONJUGATES | 2015 |
|
RU2708075C2 |
